|
WDR67 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.692200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.080200E-01 |
| Normal-vs-Stage2 |
1.619630E-01 |
| Normal-vs-Stage3 |
6.873600E-02 |
| Normal-vs-Stage4 |
4.535500E-03 |
| Stage1-vs-Stage2 |
9.786300E-02 |
| Stage1-vs-Stage3 |
8.005900E-02 |
| Stage1-vs-Stage4 |
6.643200E-03 |
| Stage2-vs-Stage3 |
2.163600E-02 |
| Stage2-vs-Stage4 |
5.025000E-03 |
| Stage3-vs-Stage4 |
2.289400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.312800E-01 |
| Normal-vs-AfricanAmerican |
2.461200E-01 |
| Normal-vs-Asian |
4.986100E-02 |
| Caucasian-vs-AfricanAmerican |
5.741600E-01 |
| Caucasian-vs-Asian |
1.214400E-01 |
| AfricanAmerican-vs-Asian |
7.314000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.611000E-01 |
| Normal-vs-Female |
3.988400E-01 |
| Male-vs-Female |
9.373000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.289600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.028400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.925000E-01 |
| Normal-vs-Age(81-100Yrs) |
6.821000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.500400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.562200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.807200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.767200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.799400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.899200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.423900E-02 |
| Classical-VS-Follicular |
3.990600E-01 |
| Classical-VS-Other |
5.409400E-01 |
| Classical-VS-Normal |
3.561200E-01 |
| Tall-VS-Follicular |
6.016400E-02 |
| Tall-VS-Other |
3.759800E-01 |
| Tall-VS-Normal |
3.221700E-02 |
| Follicular-VS-Other |
5.491200E-01 |
| Follicular-VS-Normal |
8.389400E-01 |
| Other-VS-Normal |
6.308600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.472000E-01 |
| Normal-vs-N1 |
2.411600E-02 |
| N0-vs-N1 |
5.722200E-02 |
|
|
